Details
Category: Volume 07 Issue 01 January 2019
Hits: 1305

Title: Study of Epidemiology of Diabetic Retinopathy in Central India (SEDI)

Authors: Dr Kavita Dhabarde, Dr Minal Vyawhare, Dr Vandana Iyer, Dr Avinash Puri

 DOI: https://dx.doi.org/10.18535/jmscr/v7i1.84

Abstract

 

Background: Diabetic retinopathy (DR), an imperative sequel is posing huge threat of blindness because of substantial prevalence of diabetes in the population of Central India. In depth understanding of its risk factors is relatively unexplored in this region.

Objective: To identify the prevalence and risk predictors of diabetic retinopathy in Central India.

Methods: A cross sectional study was conducted in 300 type 2 diabetic subjects of age >40 years. Consenting subjects were tested with dilated pupil fundoscopy and categorized into non proliferative (NPDR) and proliferative diabetic retinopathy (PDR) according to ETDRS Classifiction.

Results: Univariate regression analysis revealed advancing age (>60 years), duration of diabetes (DOD) >10 years, systolic (>120mmHg), obesity, smoking, proteinuria, Hyperlipdemia (total cholesterol >200mg/dl), as risk factors. In multivariable logistic regression analysis, age>60 years, DOD>10 years, SBP>120mmHg, total cholesterol >200mg/dl, raised blood sugar level were observed to be substantial risk variables influencing independently the risk of DR in the population of Central India.

Conclusion: Prevalence of Diabetic Retinopathy in Central India is 30.33% with Age of the patient, duration of diabetes, uncontrolled blood sugar, hypertension, hyperlipidemia being important factors for development & progression of DR. The primary prevention intervention for DR is good diabetes management through the control of blood sugar, blood pressure & lipids, maintaining healthy weight & cessation of smoking.

Keywords: prevalence of diabetic retinopathy ,risk factors, NPDR, PDR, macular edema.

References

  1. International Diabetes Federation. Diabetes atlas. 8th ed 2017
  2. WHO Global Report on Diabetes 2016
  3. Congdon NG, Friedman DS, Lietman T. Important causes of visual impairment in the world today. JAMA 2003; 290: 2057–60; DOI: http://dx.doi.org/10.1001/ jama.290.15.2057
  4. Fong DS, Aiello L, Gardner TW, et al. Retinopathy in diabetes. Diabetes Care 2004; 27 Suppl 1: S84-87
  5. Nick Kourgialis - Hellen Keller International. Vision Atlas. Available at: http://atlas.iapb.org/ vision-trends/diabetic-retinopathy.
  6. Yau JW, Rogers SL, Kawasaki R, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 2012; 35: 556–64; DOI: http://dx.doi.org/10.2337/dc11- 1909.
  7. American Society of Ophthalmology. Diabetic Retinopathy Diagnosis. American Academy of Ophthalmology, 2017
  8. The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin- Dependent Diabetes Mellitus. N Engl J Med 1993; 329: 977–86; DOI: http://dx.doi.org/10.1056/ NEJM199309303291401.
  9. King P, Peacock I, Donnelly R. The UK Prospective Diabetes Study (UKPDS): clinical and therapeutic implications for type 2 diabetes. Br J Clin Pharmacol 1999; 48: 643–8; DOI: http://dx.doi.org/10.1046/ j.1365-2125.1999.00092.x.;
  10. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 1984;102:520-6, 527-32
  11. Souza EC, Esteves JF, Broilo VR, Domingues CG, Lavinsky J. Retinopatia diabética não proliferativa. In: Abujamra S, Ávila M, Barsante C, Farah ME, Gonçalves JOR, Lavinsky J, et al, editores. Retina e vítreo: clínica e cirurgia.São Paulo: Rocca;2000. 485-99.
  12. Harris MI: Undiagnosed NIDDM: clinical and public health issues. Diabetes Care 16:642-652,1993
  13. Harris M, Klien R, Welborn T, Knuiman M: Onset of NIDDM occurs at least 4–7 years before clinical diagnosis. Diabetes Care 15:815–819, 1992
  14. MacKinnon JR, Forrester JV: Diabetic retinopathy. In Oxford Textbook of Endocrinology and Diabetes . Wass JAH, Shalet SM, Eds. Oxford, U.K., Oxford University Press, 2002, p. 1764– 1778
  15. Klein R, Klein B. Epidemiology of Proliferative Diabetic Retinopathy. Diabetes Care. 1992;15:1875-91
  16. Yanko L, Goldbourt U, Michealson C, et al. Prevalence and 15 year incidence of retinopathy and associated characteristics in middle-aged and elderly diabetic Br J Ophthalmol.1983;67:759-765
  17. Namperumalsamy, R. Kim, TP Vignesh, et al. Prevalence and risk factors for diabetic retinopathy : A population – based assessment from Thani District, South India. Br J Ophthalmol 2009;93:429-434.
  18. Salil Gadkari et al. Prevalence of diabetic retinopathy in India: The All India Ophthalmological Society Diabetic Retinopathy Eye Screening Study 2014. IJO 2016; VOL 64; Page 38-44.
  19. Rema M, Premkumar S, Anitha B, Deepa R, Pradeepa R, Mohan V. Prevalence of Diabetic Retinopathy in urban india: The Chennai Urban Rural Epidermiology Study (CURES) eye study,1.Invest Ophthalmol Vis Sci 2005;46:2328-33
  20. Dandona L, Dandona R, Naduvilath TJ, McCarty CA, Rao GN. Population based assessment of diabetic retinopathy in an urban population in southern India. Br J Ophthal 1999; 83 : 937-40.
  21. Ramachandran A, Snehalata C, Satyavani K, Latha E, Sasikala R, Vijay V. Prevalence of vascular complications and their risk factors in type 2 diabetes. Jour Assoc Phy India 1999; 47: 1152-6.
  22. Knuiman MW, Welborn TA, McCann VJ, Stanton KG, Constable IJ. Prevalence of diabetic complications in relation to risk factors. Diabetes 1986; 35: 1332-9.
  23. Raman R et al. Prevalence of diabetic retinopathyin India: Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetics Study report 2.Ophthalmology 2009 Feb; 116(2):311-8
  24. Chatziralli et al., Risk factors associated with diabetic retinopathy in patients with diabetes mellitus type 2 BMC Research Notes 2010, 3:153
  25. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ 1998;317:703-13.
  26. Kohner EM. Diabetic retinopathy. Br Med Bull 1989;45:148-73.
  27. Prevalence of Diabetic Retinopathy in Type 2 Diabetes in Relation to Risk Factors: Hospital Based Study. Agrawal R P, Ranka M, Beniwal R, Gothwal S R, Jain G C, Kochar D K, Kothari R P Year : 2003 | Volume: 23 | Issue Number: 1 Page: 16-19
  28. Rema M, Shanthirani CS, Deepa R, Mohan V. Prevalence of diabetic retinopathy in a selected South Indian Population - The Chennai Urban Population Study (CUPS). Diabetes Res Clin Pract 2000; 50 : S252
  29. Klein R, Klein BE, Moss SE, Cruickshanks KJ. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in Type 1 Ophthalmology 1998; 105 : 1801-15
  30. Dirani et al. Are obesity and anthropometry risk factorsfor diabetic retinopathy? The diabetes management project. Invest Ophthalmol Vis Sci. 2011 Jun 22; 52(7): 4416-21.
  31. Ronald Klein et al, The Wisconsin Epidemiologic Study of Diabetic Retinopathy XXII. The Twenty-Five-Year Progression of Retinopathy in Persons with Type 1 Diabetes, Ophthalmology 2008, 115(11), 1859-68
  32. Van Leiden HA et al. Blood pressure, lipids, and obesity are associated with retinopathy: the hoorn study. Diabetes Care, 2002 Aug,25(8): 1320-5.
  33. Ranil PK et al. Anemia and diabetic retinopathy in type 2 diabetes mellitus. J Asso Physicians India, 2010 Feb; 58, 91-4
  34. Moss SE et al. Cigarette smoking and ten-year progression of diabetic retinopathy. Ophthalmology 1996 sep; 103(9): 1438-42

Corresponding Author

Dr Minal Vyawhare

Email: This email address is being protected from spambots. You need JavaScript enabled to view it., Mobile- +91 9975762049